EUVIMEDEUVIMED entdecken
Studienprotokoll

Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study

Leonardo D Garma iD, Sonia Pernas iD, David Vicente Baz, Rosario García Campelo iD, Josefa Terrasa, Berta Nasarre iD, Ruth Vera García iD, Begoña Bermejo iD, Santiago González Santiago iD, Bartomeu Fullana iD, Mario Rodríguez-Pérez, Manuel Fernandez Bruno iD und 23 weitere

JCO Precision Oncology · 2026

DOI: 10.1200/po-25-01185 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift JCO Precision Oncology, 2026. Verfasst von Leonardo D Garma und 34 weiteren Autor:innen. Beteiligte Einrichtung: Breast Cancer Clinical Research Unit, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain. Hauptthemen laut MEDLINE: Breast Neoplasms, Colorectal Neoplasms, Lung Neoplasms. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE A substantial proportion of patients receiving genomically matched therapies do not achieve clinical benefit, underscoring the influence of nongenetic factors on cancer outcomes. High-Definition Oncology (HDO) proposes integrating longitudinal, multimodal patient data—spanning clinical, molecular, physiological, and behavioral domains—to enable truly individualized cancer care. This manuscript describes the HDO study design, framework, and feasibility results in women with metastatic cancer. METHODS We initiated a prospective, multicenter observational study (HDO study; ClinicalTrials.gov identifier: NCT06590506 ) enrolling 300 female patients with newly diagnosed metastatic breast, lung, or colorectal cancer. Here, we report the study design, standardized workflows, prespecified feasibility criteria, and early internal pilot results. Eleven data modalities are collected longitudinally, including tumor and germline genomics, germline epigenomics, gut microbiome, blood and stool metabolomics and proteomics, exposome characterization, wearable-derived physiological monitoring, digital footprint assessment, medical imaging, and patient-reported outcomes. Standardized workflows govern clinical procedures, data acquisition, biospecimen processing, and quality control across all participating sites. RESULTS Feasibility was evaluated in the first 30 participants (10% of planned accrual). Patients completed 100% of scheduled clinical visits, 97.4% of planned plasma collections, 80.7% of stool samples, and all tumor biopsies. Wearable devices captured activity, heart rate, sleep, and blood oxygen saturation data during 95.0%, 84.2%, 90.6%, and 70.7% of total patient-days, respectively. Biospecimens met predefined quality control metrics across all molecular modalities. Engagement with mobile applications for pain and emotion reporting exceeded 80%. CONCLUSION The HDO study demonstrates the feasibility of comprehensive, longitudinal, multimodal data collection in women with metastatic cancer. This internal pilot establishes an integrated framework for future analyses aimed at characterizing disease trajectories, defining molecular and physiological determinants of outcomes, and developing patient-specific computational models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsColorectal NeoplasmsLung NeoplasmsAdultAgedFemaleHumansMiddle AgedFeasibility StudiesLongitudinal StudiesMulticenter Studies as TopicNeoplasm MetastasisPilot ProjectsProspective StudiesObservational Studies as Topic

Autor:innen und Institutionen

  • Breast Cancer Clinical Research Unit, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain.
  • Institut Catala d'Oncologia (ICO)-Institut d'Investigació Biomèdica de Bellvitge, Barcelona, Spain.
  • Hospital Virgen de la Macarena, Sevilla, Spain.
  • Medical Oncology Service, University Hospital A Coruña (XXIAC-SERGAS), A Coruña, Spain.
  • Department of Medical Oncology, Hospital Son Espases, Palma de Mallorca, Spain.
  • Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.

ORCID-Profile: Leonardo D Garma, Sonia Pernas, Rosario García Campelo, Berta Nasarre, Ruth Vera García, Begoña Bermejo, Santiago González Santiago, Bartomeu Fullana, Manuel Fernandez Bruno, Cristina Reboredo Rendo, Juan Antonio Guerra, Virginia Arrazubi, Susana de la Cruz, Cristina Tebar, Elena Núñez Berrueco, Berta Hernández-Marín, Jacobo Rogado, Leire P Arbaizar, Jon Sanz-Landaluze, Gustavo Moreno-Martín, Aída Morillas, Antonio Lopez-Alonso, Alfonso Rodríguez-Patón, Antonio Artés-Rodríguez, Miguel Quintela-Fandino

Zitieren

APA

Garma, L. D., Pernas, S., Vicente Baz, D., García Campelo, R., Terrasa, J., Nasarre, B., Vera García, R., Bermejo, B., González Santiago, S., Fullana, B., Rodríguez-Pérez, M., Fernandez Bruno, M., Reboredo Rendo, C., Perelló, A., Jiménez, D., Guerra, J. A., Arrazubi, V., de la Cruz, S., Cejalvo, J. M., …, & Quintela-Fandino, M. (2026). Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study. JCO Precision Oncology. https://doi.org/10.1200/po-25-01185

Vancouver

Garma LD, Pernas S, Vicente Baz D, García Campelo R, Terrasa J, Nasarre B, et al. Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study. JCO Precision Oncology. 2026. doi:10.1200/po-25-01185

BibTeX
@article{Garma2026,
  author = {Garma, Leonardo D and Pernas, Sonia and Vicente Baz, David and García Campelo, Rosario and Terrasa, Josefa and Nasarre, Berta and Vera García, Ruth and Bermejo, Begoña and González Santiago, Santiago and Fullana, Bartomeu and Rodríguez-Pérez, Mario and Fernandez Bruno, Manuel and Reboredo Rendo, Cristina and Perelló, Antonia and Jiménez, Desirée and Guerra, Juan Antonio and Arrazubi, Virginia and de la Cruz, Susana and Cejalvo, Juan Miguel and Tebar, Cristina and Núñez Berrueco, Elena and Hernández-Marín, Berta and Rogado, Jacobo and Olmos, Pablo M and Arbaizar, Leire P and Villalba Oliva, Miguel A and Madrid, Yolanda and Sanz-Landaluze, Jon and Moreno-Martín, Gustavo and Morillas, Aída and Lopez-Alonso, Antonio and Rodríguez-Patón, Alfonso and Colomer, Ramón and Artés-Rodríguez, Antonio and Quintela-Fandino, Miguel},
  title = {Longitudinal Clinical, Physiological, and Molecular Profiling of Female Patients With Metastatic Cancer: Protocol and Feasibility of a Multicenter High-Definition Oncology Study},
  journal = {JCO Precision Oncology},
  year = {2026},
  doi = {10.1200/po-25-01185}
}
Kostenlos starten →